Spoiler alert: Yes.
Even if this is entirely about equity, it’s a strange call. Monoclonal antibody treatment saves lives, and should be distributed based on need. Most medicines and treatments don’t have to get distributed by the federal government, but for those that do because of shortage conditions, are any distributed on the basis of prioritizing equity over demand?
This smells a bit like retribution for red-state governors not playing along with Biden’s demands for mandates and masks. That aroma arises from Biden himself, who vowed last week to get even with such governors to “get them out of the way.” The timing is suspicious in more ways than one, too:
- New Peer-Reviewed Study Shows Ivermectin ‘Significantly’ Reduces COVID Infections, Hospitalization, and Mortality
- MIT Scientist Warns About Covid Vaccine on the Brain
- Wait. What? Pfizer CEO now says 2 COVID shots “offers very limited protection, if any,” against COVID-19.
- BREAKING: Biden Administration Making Lists of Religious Vaccine Objectors
- Inside the January 6th Setup– Who is Ray Epps?
- SCOTUS Ruling on OSHA mandate expected today
- Teacher alleges she was fired for not ‘meowing’ back at student who identifies as a cat
- Professor Absolutely Loses it on Zoom. (NSFW) “You are all just vectors of disease to me!”
- Insane — Canada court rules father cannot criticize COVID vaccines around 10-year-old son
- Tyranny — New infrastructure bill grants U.S. gov’t ability to disable vehicles remotely